Questions with no answer at all. Not questions with no accepted answer — those are elsewhere.
What I am working with: SURPASS-2 · tirzepatide. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
Setup, so nobody has to ask: FGP · Tianjin · the Netherlands. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not…
I have certificates from two lots and an independent result on one of them. I would rather over-plan the first cycle and simplify later. I am prepared to do the work…
The particulars: +4 · 4113.6 Da. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not used an online calculator because I…
Details up front: MKM · ecnoglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would like…
Details up front: mazdutide · 10 mg. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method is…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I can predict the outcome but I cannot explain it, which means I will get the…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I would like to understand the steps well enough to explain them to someone…
What I have: 30 mg · orforglipron. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I would rather…
The case in front of me: hair thinning · eight · orforglipron. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have…
Conditions: semaglutide · SELECT. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how confident…
Setup, so nobody has to ask: retatrutide · 3.33 mg/mL. I have worked this out and I would like someone to find the error, because I suspect there is one. My working…
What I am working with: SURMOUNT-5 · injection-site erythema · 15 mg. I would like help reading this properly rather than being told what conclusion to reach. I have…
What I am working with: 2.5 mg/mL · a GLP-1 receptor agonist. Both of these get recommended confidently by different people, which suggests neither is obviously…
For context, I am working with a 10 mg presentation and a 2 mL fill. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will…
The specifics, since they change the answer: Xianning · Norway. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
My setup is a refrigerator with a logger and a small work area I wipe down, nothing more. I want the working, not the result — I need to be able to redo it with…
The case in front of me: ecnoglutide · four weeks · 4 °C. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and…
For reference: oral semaglutide · ten weeks · 2–8 °C. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have…
Setup, so nobody has to ask: SSA · CPC · the United States. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments…
Conditions: ERP · Shanghai Sigma-Audley. Both of these get recommended confidently by different people, which suggests neither is obviously right. My constraints are…
Setup, so nobody has to ask: a formic acid mobile phase · mazdutide · a wide-pore C18 column. The empirical answer seems settled. The explanation does not. If the…
Conditions: mazdutide · cagrilintide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible reason…
I have the full paper rather than the abstract, and the supplementary appendix. I would like the mechanism, because I want to be able to reason about the cases nobody…